4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-23-044381
Chief Financial Officer acquired 18,165 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRATES JAMES M Chief Financial Officer | 2023-08-23 | Option exercise | +18,165 | $6.88 | $124,975 | 106,341 | D |
| Derivatives | |||||||
| FRATES JAMES M Chief Financial Officer | 2023-08-23 | Option exercise · Stock Option (right to buy) | −18,165 | 363,835 | D | ||
Loading xslF345X05/ownership.xml…